PERFECTHA SUBSKIN LIDO (3x1ml) OBVIELINE

PERFECTHA SUBSKIN LIDO (3x1ml) OBVIELINE

USAGE MEDICAL. PERFECTHA is a Class III medical device, in accordance with the EU Medical Device Directive 93/42/ EEC.

DESCRIPTION

• NEW.
• PERFECTHA SUBSKIN LIDOCAINE is a biphasic BDDE cross-linked hyaluronic acid 20 mg/ml with lidocaine.
• Facial contour malar regions, chin and cheeks, treatment of certain cuts. Treatment of som depression and scarring.
• PERFECTHA SUBSKIN for regaining beauty with a natural look. Formulated for large losses of volume including augmenting the jaw, the chin and the cheeks as well as rejuvenation of the hands.

INDICATIONS

• Volume creation.
• Facial contours.
• Malar areas.
• Chin and cheeks.
• Nose bridge.
• Hands.

COMPOSITION PERFECTHA SUBSKIN

• HA 20 mg/ml. 20 mg/ml of hyaluronic acid. HA Origin: Non Animal.
• 2 000 gel particles/ ml. 
• Lidocaine hydrochloride 0.3%.
• Crosslinking Rate: 90%.
• Volumizing capacity particles size: ++++.
• Injection depth: subcutaneous and Supra-periosteal
• Injection sites: Facial Contour. Jaw bones, chin and cheek areas.
• Treatment of some depression and scarring.

PRESENTATION

Syringe: 3 x 1ml .
Gel volume: 3 of 1mL.
Needles: 1 cannula and needle 21G x 50 mm.
Stockage à l'abri du gel et de la lumière: Entre 2°C et 30°C.

DURABILITE

Remanence: Between 12 and 18 months.

RESULTS

PERFECTHA provides optimal results with low injection volume. PERFECTHA is easy to inject due to excellent flow properties. PERFECTHA is long lasting with slow and uniform degradation. Perfectha has a hydrating effect.

PERFECTHA is manufactured in FRANCE at the ObvieLine Laboratory located in Dardilly, nearby Lyon. Created in 2005 and acquired by Sinclair Pharma in 2014, ObvieLine Laboratory designs, develops and manufactures all the PERFECTHA range products.